GUIDELINES FOR DIAGNOSIS, TREATMENT AND MONITORING PATIENTS WITH SMALL CELL LUNG CANCER

Autori:

Miroslav Samaržija, Marko Jakopović, Marijo Boban, Lidija Bošković, Ingrid Belac Lovasić, Antonio Juretić, Damir Gugić, Jasna Radić, Sven Seiwerth, Snježana Tomić, Ksenija Lučin, Sanja Pleština, Mihovil Roglić, Joško Juričić, Silvana Smojver Ježek, Dinko Stančić-Rokotov, Ivica Mažuranić, Suzana Kukulj, Krešimir Dolić, Dragan Arar, Melita Kukuljan, Eduard Vrdoljak

Sažetak
Rak pluća najučestalija je zloćudna bolest u muškaraca, a pri vrhu je učestalosti i u žena. Među oboljelima 15% čine bolesnici s rakom pluća malih stanica. S obzirom na agresivnu prirodu ove bolesti i lošu prognozu, vrlo je važno definirati i implementirati standardizirani pristup dijagnostičkoj obradi, liječenju, kao i praćenju ovih bolesnika. Metode liječenja uključuju kemoterapiju, radioterapiju i, rijetko, kirurgiju ovisno o stadiju bolesti i općem stanju bolesnika.
Summary

Lung cancer is the most common male cancer, and one of the most common female cancers. Small cell lung cancers account for 15% of lung cancers. Due to the aggressiveness of the disease and bad prognosis, it is important to define and implement standardized approach for diagnostics, treatment and monitoring of these patients. Treatment modalities include chemotherapy, radiotherapy, and, rarely, surgery according to the stage of the disease and patient condition.